FOXO3 and diabetes mellitus: The expression of FoxO3a, which functions as an intermediary regulator of anabolic and catabolic pathways, exhibited a substantial increase of 2.78-fold and 3.63-fold in the soleus and EDL muscles, respectively, of rats with STZ-induced diabetes when compared to the control group (p < 0.001).